The cell surface marker CD69 is rapidly upregulated on many immune cell types after activation, and correlations have been made between Natural Killer (NK) cell CD69 expression and NK cell-mediated tumor-killing activity in the classical target cell-based assay, by a number of research teams over the past 25 years. Here, CD69 is linked to neoplasm.